Episode Synopsis "Investors look to biotech with COVID-19 vaccine on the horizon"

Welcome to another podcast focusing on the topic du jour, indeed, the topic of the decade, even the topic of the century, biotechnology and the current pandemic. ETF Securities have created an exchange traded fund with the apt ASX code 'Cure' which provides individual investors and SMSFs easy and inexpensive access to the US biotech market.

Listen "Investors look to biotech with COVID-19 vaccine on the horizon"

More episodes of the podcast IN Discussion

• Is there an alternative for cash and fixed interest in the new normal investment environment of low interest rates?
• Chris Briant Parametric & Peter White from IN Chats
• ETF Securities: Trade your conviction
• Inside Analysis DATT Capital
• COVID-19 and the Industrial and Logistics sector: insight from Charter Hall
• Investors look to biotech with COVID-19 vaccine on the horizon
• CEO Series with Federation AM CEO Cameron Brownjohn
• Equities, dividends and Covid-19
• The sting in the transition tail